Elena Ridloff - 29 Jun 2022 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
Director
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
Issuer symbol
KYMR
Transactions as of
29 Jun 2022
Net transactions value
$0
Form type
4
Filing time
01 Jul 2022, 16:05:15 UTC
Previous filing
29 Jun 2022
Next filing
20 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KYMR Stock Option (Right to Buy) Award $0 +9,000 $0.000000 9,000 29 Jun 2022 Common Stock 9,000 $20.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years beginning on June 29, 2022.